Regulatory & Legal

Scienture Holdings' Arbli™ just gained 12.5M covered lives. It's not about the $219M market, but the overlooked patients who can't swallow pills.

Amid a spiraling insurance crisis, a new company called Stand is betting it can fix Florida's broken market by modeling risk down to the nail and rewarding resilience.

R1's new Phare OS intelligence engine promises to upend the slow, costly cycle of medical claims. Can real-time adjudication finally fix a broken system?

A new European patent grants WISeKey the power to embed NFTs into physical chips, creating an unforgeable, quantum-proof link between art and its identity.

A massive $600M financing deal for a solar and battery project in California signals a new era of strategic investment in renewable infrastructure.

A new partnership between Charles River and Lilly TuneLab merges AI with nonclinical testing, aiming to fast-track new medicines and level the field for biotechs.

Eason Technology leadership's big share purchase signals confidence. But with declining revenue and a "going concern" warning, is this a bet on a real turnaround?

A new UN-nonprofit partnership aims to transform methane monitoring from a passive exercise into a rapid response system, targeting oil and gas super-emitters.

A new alliance aims to solve AI's biggest problem: moving from costly experiments to real-world value. This is the blueprint for the next era of automation.

Alight's 1-for-20 reverse split aims to save its NYSE listing. Is this a savvy strategic reset or a temporary fix for a stock facing deeper challenges?

A hidden crisis is cleaving the tech world in two. As AI giants consume the global supply of advanced chips, everyone else faces a growing famine.

As AI agents act with growing autonomy inside business tools, a new solution from MSPAlliance offers unprecedented visibility, shifting risk from a guess to a science.

AudioEye appoints Matthew Domeyer as CFO, a strategic move to manage 41 quarters of growth and capitalize on regulatory tailwinds in the booming accessibility market.

A new Slovak fintech offers zero-fee ETF investing to fight inflation. But what's the catch? We analyze the business model shaking up Central European finance.

Rixos's new Hurghada resort is a strategic play on surging Polish demand, betting big on Egypt's luxury tourism future and its ambitious Vision 2030.

Insurtech leader ZestyAI adds a software scaling CFO and a P&C veteran to its team, capitalizing on cash-flow positivity and major client wins.

An investor tour reveals China's stunning sustainable tech, but the real challenge is financial. Can high-tech farms prove they are 'bankable'?

With enhanced GMP cell banking suites, Minaris integrates manufacturing and testing in Philadelphia, aiming to accelerate development in the booming CGT market.

With a fresh $50M, Enhanced Group is selling a future of medically-guided peak performance. But can its controversial Games and peptide platform survive regulatory scrutiny?

A new spray-dried plasma could end reliance on freezers, transforming trauma care from the battlefield to rural ERs. But can Velico navigate the path to market?